Group 1 - The company, China Nuclear Industry, announced an expected revenue of approximately 6.979 billion to 7.206 billion yuan for 2025, representing a year-on-year decline of about 5% to 8% [1] - The net profit is projected to be between 611 million to 655 million yuan, indicating a year-on-year decrease of approximately 25% to 30% [1] - The attributable net profit is expected to range from 302 million to 322 million yuan, reflecting a year-on-year decline of about 20% to 25% [1] Group 2 - The revenue decrease for 2025 is primarily attributed to a decline in the company's nuclear medical equipment segment [1] - The profit reduction is mainly due to the impact of tax payments and late fees from the subsidiary, Shenzhen Zhonghe Haidewei Biotechnology Co., Ltd. [1]
中国同辐：2025年净利润预计为6.11亿元至6.55亿元，附属公司中核海得威生物被要求补缴税费及滞纳金